Zobrazeno 1 - 10
of 81
pro vyhledávání: '"E Gautherot"'
Publikováno v:
The Journal of Immunology. 146:169-175
In order to target specifically double-Ag-positive cells in vivo, we synthesized chemically two mAb conjugates with specificities for both an allelic murine B cell-surface Ag and for a synthetic hapten. One conjugate was designed for its specificitie
Autor:
J P, Vuillez, F, Kraeber-Bodéré, D, Moro, M, Bardiès, J Y, Douillard, E, Gautherot, E, Rouvier, J, Barbet, F, Garban, P, Moreau, J F, Chatal
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5
As small cell lung carcinoma (SCLC) is frequently a widespread disease at diagnosis, highly radiosensitive and often only partially responsive to chemotherapy, radioimmunotherapy (RIT) would appear to be a promising technique for treatment. We report
Autor:
F, Kraeber-Bodéré, S, Bardet, C A, Hoefnagel, M R, Vieira, J P, Vuillez, A, Murat, T C, Ferreira, M, Bardiès, L, Ferrer, I, Resche, E, Gautherot, E, Rouvier, J, Barbet, J F, Chatal
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 5
The toxicity and therapeutic efficacy of escalating doses of anti-carcinoembryonic antigen x anti-N alpha-(diethylenetriamine-N,N,N',N''-tetraacetic acid)-In bispecific monoclonal antibody (F6-734) and iodine 131-labeled bivalent hapten were determin
Autor:
M, Hosono, M N, Hosono, F, Kraeber-Bodéré, A, Devys, P, Thédrez, A, Faivre-Chauvet, E, Gautherot, J, Barbet, J F, Chatal
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 40(7)
The "affinity enhancement system," a two-step targeting technique using bispecific antibody and radiolabeled bivalent hapten, has been reported to be useful for carcinoembryonic antigen-expressing tumors. The purpose of this study was to evaluate the
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(11)
Two-step pretargeting strategies have been designed to deliver radioisotopes to tumors more selectively than directly labeled antibodies or fragments. In this article, we compare quantitatively the potential of these strategies for the radioimmunothe
Autor:
M, Hosono, M N, Hosono, F, Kraeber-Bodéré, A, Devys, P, Thédrez, M, Fiche, E, Gautherot, J, Barbet, J F, Chatal
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 39(9)
The purpose of this study was to evaluate biodistributions and absorbed doses of anti-carcinoembryonic antigen (CEA)/anti-diethylenetriamine pentaacetic acid (DTPA)-indium (anti-DTPA-In) bispecific monoclonal antibody (BsMAb) F6-734 and 125I-labeled
Publikováno v:
Cancer. 80
One of the main limitations of radioimmunotherapy (RIT) is the secondary toxicity related to the poor therapeutic indices achieved with labeled whole immunoglobulin (Ig)G or F(ab')2 fragments. To overcome this problem, we have developed a two-step ta
Publikováno v:
Hormone research. 47(4-6)
The present article reviews the clinical trials that have been performed in recurrent medullary thyroid carcinoma patients with the Affinity Enhancement System. This technique uses bispecific antibodies to target radiolabelled bivalent haptens to tum
Autor:
M, Bardiès, S, Bardet, A, Faivre-Chauvet, P, Peltier, J Y, Douillard, M, Mahé, M, Fiche, A, Lisbona, F, Giacalone, P, Meyer, E, Gautherot, E, Rouvier, J, Barbet, J F, Chatal
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 37(11)
The purpose of this study was to estimate the dose delivered to tumor targets and normal tissues after two-step injection of an anti-CEA/anti-DTPA-In (F6-734) bispecific antibody and a 131I-labeled di-DTPA in-TL bivalent hapten in patients with medul
Publikováno v:
Journal of interferon research. 14(5)